日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Avenciguat: a novel soluble guanylate cyclase activator that affects multiple cell types to inhibit IFN-1 signalling and fibrosis

阿文西呱:一种新型可溶性鸟苷酸环化酶激活剂,可影响多种细胞类型,抑制IFN-1信号传导和纤维化。

Kaufman, Julia; Nabozny, Gerald; Tran-Manh, Cuong; Liebel, Christoph; Zhou, Xiang; Daley, Lee-Anne; Wang, Chao-Ting; Ebenezer, David L; Delic, Denis; Wohnhaas, Christian T; Trinh-Minh, Thuong; Distler, Jörg H W

Assessing ad-hoc adaptations' alignment with therapeutic goals: a qualitative study of lay counselor-delivered family therapy in Eldoret, Kenya

评估临时调整与治疗目标的一致性:一项关于肯尼亚埃尔多雷特非专业咨询师提供的家庭治疗的定性研究

Kaiser, Bonnie N; Kaufman, Julia; Wall, Jonathan Taylor; Healy, Elsa A Friis; Ayuku, David; Aarons, Gregory A; Puffer, Eve S

Dendritic cell vaccines containing lymphocytes produce improved immunogenicity in patients with cancer.

含有淋巴细胞的树突状细胞疫苗可提高癌症患者的免疫原性

Frank Mayu O, Kaufman Julia, Parveen Salina, Blachère Nathalie E, Orange Dana E, Darnell Robert B

Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer.

利用肿瘤自然产生的免疫力:前列腺癌临床疫苗试验

Frank Mayu O, Kaufman Julia, Tian Suyan, Suárez-Fariñas Mayte, Parveen Salina, Blachère Nathalie E, Morris Michael J, Slovin Susan, Scher Howard I, Albert Matthew L, Darnell Robert B